In contrast with the AKBA 50 mg/kg treatment group, the AKBA 100 mg/kg was more effective in restoring the Nrf2 and HO-1 protein levels than EB-induced MS rats (Figure 9A–D). This evidence concerns the gene NFE2L2 and myeloid sarcoma.